Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 3/2012

01-03-2012 | Research Articles

Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients

Authors: Yanyang Tu, Shiming He, Jianfang Fu, Gang Li, Ruxiang Xu, Hongliu Lu, Jianping Deng

Published in: Clinical and Translational Oncology | Issue 3/2012

Login to get access
Metadata
Title
Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients
Authors
Yanyang Tu
Shiming He
Jianfang Fu
Gang Li
Ruxiang Xu
Hongliu Lu
Jianping Deng
Publication date
01-03-2012
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 3/2012
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0786-2

Other articles of this Issue 3/2012

Clinical and Translational Oncology 3/2012 Go to the issue

Educational Series / Red Series

Castration-resistant metastatic prostate cancer: current status and treatment possibilities

Editorial

Is there any role for new prognostic markers in breast cancer?

Research Articles

Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis

Special Article

Consensus of the Spanish Society of Radiation Oncology (SEOR) Brachytherapy Group on brachytherapy in Breast Cancer

Research Articles

Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas

Brief Research Article

Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits